NCT01425008 2020-08-10Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic MelanomaTakedaPhase 1 Completed149 enrolled 43 charts
NCT02327169 2020-02-25A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic MalignanciesTakedaPhase 1 Completed81 enrolled 33 charts